# The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease

> **NCT01508663** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 1600 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Everolimus Eluting Stent or Zotalolimus Eluting Stent
- **DRUG:** ARB, CCB, ACE-inhibitor, statin, Nitrate, Antiplate etc.

## Key facts

- **NCT ID:** NCT01508663
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2014-02
- **Final completion:** —
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2012-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01508663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01508663, "The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01508663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*